Showing results (111-120 of 172) with videos related to
Sort By:
Pageof 18
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of cystemustine in metastatic colorectal carcinoma. A trial of the EORTC Clinical Screening GroupP Kerbrat, A Adenis, P Rebattu, et al.European Journal of Cancer & Clinical Oncology|December 1, 1988
Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trialJ Bonneterre, L Mauriac, B Weber, et al.Annales D'Urologie|January 1, 1987
[Current role of oncostatic chemotherapy in malignant testicular tumors]Y J Bignon, J Dauplat, J P Ferrière, et al.International Journal of Cancer|July 15, 1999
O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulationC Rolhion, F Penault-Llorca, J L Kemeny, et al.Experimental Cell Research|March 1, 1988
Evidence of 3 beta-hydroxysteroid dehydrogenase activity in several murine embryonal carcinoma cell linesC Touzet, Y J Bignon, M Afane, et al.In Vivo (Athens, Greece)|March 1, 1990
Immunohistochemical evaluation of reverse transcriptase in breast carcinoma with polyclonal antibodies raised in rabbitC F Moyret, D J Bernard, J C Maurizis, et al.Cancer Treatment Reviews|October 31, 2003
Methionine dependency and cancer treatmentE Cellarier, X Durando, M P Vasson, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2002
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiformeE Raymond, M Campone, R Stupp, et al.European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancerP Soulié, A Bensmaïne, C Garrino, et al.European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: a trial of the EORTC Early Clinical Studies GroupH Curé, I Krakowski, A Adenis, et al.Pageof 18